The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
After hours: March 24 at 7:44:11 PM EDT Loading Chart for VRTX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback